2025. Efficacy of Deucravacitinib over time in Psoriasis by Baseline Total Body Surface Area: Post Hoc Analysis of the Randomized, Double-blind, Placebo-controlled Phase 3b/4 PSORIATYK SCALP Trial. SKIN The Journal of Cutaneous Medicine. 9, 2 (Mar. 2025), s537. DOI:https://doi.org/10.25251/skin.10.supp.537.